Langerhans cells are more efficiently transduced than dermal dendritic cells by adenovirus vectors expressing either group C or group B fibre protein: Implications for mucosal vaccines

This publication has 24 references indexed in Scilit:

• Mature Human Langerhans Cells Derived from CD34+ Hematopoietic Progenitors Stimulate Greater Cytolytic T Lymphocyte Activity in the Absence of Bioactive IL-12p70, by Either Single Peptide Presentation or Cross-Priming, Than Do Dermal-Interstitial or Monocyte-Derived Dendritic Cells
  The Journal of Immunology, 2004
• Enhanced Gene Transfer to Mouse Dendritic Cells Using Adenoviral Vectors Coated with a Novel Adapter Molecule
  Molecular Therapy, 2004
• CD46 is a cellular receptor for group B adenoviruses
  Nature Medicine, 2003
• Efficient Targeting of Protein Antigen to the Dendritic Cell Receptor DEC-205 in the Steady State Leads to Antigen Presentation on Major Histocompatibility Complex Class I Products and Peripheral CD8+ T Cell Tolerance
  The Journal of Experimental Medicine, 2002
• A High-Capacity, Capsid-Modified Hybrid Adenovirus/Adeno-Associated Virus Vector for Stable Transduction of Human Hematopoietic Cells
  Journal of Virology, 2002
• Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity
  Nature, 2002
• A Capsid-Modified Adenovirus Vector Devoid of All Viral Genes: Assessment of Transduction and Toxicity in Human Hematopoietic Cells
  Molecular Therapy, 2001
• Replication-deficient recombinant adenoviruses expressing the human immunodeficiency virus Env antigen can induce both humoral and CTL immune responses in mice
  Journal of General Virology, 1999
• Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells
  Journal of Clinical Investigation, 1999
• Methods for construction of adenovirus vectors
  Molecular Biotechnology, 1995